Tech Company Financing Transactions
Medcura Funding Round
Medcura secured a $22.4 million funding round on 4/3/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/3/2024
Transaction Type
Debt
Amount
$22,400,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its lead surgical product, the LifeGel� Absorbable Hemostatic Gel.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5650 Rivertech Ct. S
Riverdale, MD 20737
USA
Riverdale, MD 20737
USA
Phone
Website
Email Address
Overview
Medcura offers barriers that keep blood where it is supposed to be-in the patient-and keep bugs, dirt and other pathogens out. Our products rapidly stop bleeding independent of the body's clotting cascade, and work on wounds of all shapes and sizes. Using safe and naturally abundant biomaterials, our FDA-cleared products treat bleeding from the battlefield to the backyard.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Tiffany
Chief Financial Officer
Richard Vincent
Chief Scientific Officer
Matthew Dowling
VP - Bus. Development
Steve Ford
VP - Manufacturing
Bruce Choi
VP - Product Management
Colleen Nye
VP - Regulatory Affairs
Elsa Abruzzo
Browse more venture capital transactions:
Prev: 4/3/2024: dappOS venture capital transaction
Next: 4/3/2024: MIACH Orthopaedics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs